ProCE Banner Activity

Future Directions in Cancer Immunotherapy Biomarker Development

Slideset Download
In this downloadable slideset, David R. Spigel, MD, highlights emerging data and next steps for the use of biomarkers in cancer immunotherapy.

Released: March 29, 2019

Expiration: March 27, 2020

No longer available for credit.

Share

Faculty

David R. Spigel

David R. Spigel, MD

Chief Scientific Officer
Director,
Lung Cancer Research Program
Sarah Cannon Research Institute
Nashville, Tennessee

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Foundation Medicine

Faculty Disclosure

Primary Author

David R. Spigel, MD

Chief Scientific Officer
Director,
Lung Cancer Research Program
Sarah Cannon Research Institute
Nashville, Tennessee